Psoriatic Arthritis Management: From Intramuscular Gold to Biologics

Philip J. Mease, MD


November 11, 2021

Phillip J. Mease, MD, reflects on the development of therapeutics for psoriatic arthritis, from intramuscular gold and oral methotrexate in former decades to the recent use of biologics. Dr Mease also describes his role in designing the first biologic trial for PsA. The etanercept trial opened the door to a new era of therapeutics, resulting in dramatically improved patient outcomes.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.